IWP
BIO icon

Icon Wealth Partners’s Bio-Rad Laboratories Class A BIO Stock Holding History

Icon Wealth Partners’s Portfolio BIO Stock Details BIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-725
Closed -$327K – 258
2020
Q2 		$327K Buy
+725
New +$320K 0.08% 179
2019
Q2 		– Sell
-45
Closed -$14K – 232
2019
Q1 		$14K Buy
+45
New +$12.1K 0.01% 620
2018
Q3 		– Sell
-38
Closed -$11K – 323
2018
Q2 		$11K Buy
+38
New +$10.5K ﹤0.01% 677
2018
Q1 		– Sell
-38
Closed -$9K – 312
2017
Q4 		$9K Buy
+38
New +$9.21K ﹤0.01% 717

Other funds holding BIO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
ACM
Atlanta Capital Management Atlanta, Georgia $22.5B AUM 9.67% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return

Icon Wealth Partners's BIO Position: Q3 2020 in Review

Icon Wealth Partners sold out of Bio-Rad Laboratories Class A (BIO) in Q3 2020, closing a stake of 725 shares — an estimated $327K sold.

Icon Wealth Partners first reported a position in BIO in Q4 2017 and held it in 4 quarters. The position peaked at $327K in Q2 2020. 479 funds tracked by Wall St. Rank hold BIO as of Q3 2020.

  • Icon Wealth Partners reported no remaining Bio-Rad Laboratories Class A position as of Q3 2020 after selling out during the quarter.
  • Icon Wealth Partners sold 725 Bio-Rad Laboratories Class A shares in Q3 2020, an estimated $327K.
  • Icon Wealth Partners first reported a position in Bio-Rad Laboratories Class A in Q4 2017 and held it in 4 quarters.
  • Icon Wealth Partners's Bio-Rad Laboratories Class A position peaked at $327K in Q2 2020.
  • 479 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q3 2020.

Based on Icon Wealth Partners's 13F filing for Q3 2020, filed 22 Oct 2020.